Kathleen Jaeger
PER
Kathleen Jaeger Jaeger
Kathleen Jaeger, president, and chief executive of the Generic Pharmaceutical Association, said the government would have to spend only another $15 million annually to eliminate the backlog of generic-drug applications. With federal and state governments spending hundreds of billions of dollars on drug purchases annually, such an investment would pay for itself quickly as the government could buy cheaper pills, Ms. Jaeger said. President and chief executive of the Generic Pharmaceutical Association, Kathleen Jaeger, said the government would have to spend only another $15 million annually to eliminate the backlog of generic-drug applications. She said that with federal and state governments spending hundreds of billions of dollars on drug purchases annually, such an investment would pay for itself quickly as the government could buy cheaper pills and that the generic-drug industry would consider fees if the drug agency would close unintended loopholes and regulatory abuses that delay the introduction of generic drugs by months and years.